| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3199604 | Journal of Allergy and Clinical Immunology | 2011 | 11 Pages |
Abstract
Monovalent inactivated 2009 H1N1 pandemic influenza vaccine was safe and provided overall seroprotection as a surrogate of efficacy. In patients older than 60 years with severe asthma, a 30-μg dose might be more appropriate.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
William W. MD, Stephen P. MD, PhD, Matthew J. PhD, Herman PhD, Eugene R. MD, Mario MD, MPH, Sally MD, Serpil C. MD, Anne M. PhD, W. Gerald MD, Nizar MD, Wendy C. MD, Kaharu MD, PhD, Scott MA, Suphagaphan MD, Madhuri MD, Benjamin MD, Ted M. PhD, Alkis MD,